Announces Plan to Exit the Skilled Nursing
Facility Business;Announces Associated $70 Million to $100
Million Cost Realignment Initiative(1)
Enterprise Strategy Focused on Stronger Cash
Flow, Higher Margin, Lower Capital Intensity Businesses
Third Quarter Consolidated Revenues of $1.8
Billion, GAAP Loss from Continuing Operations of $671 Million, GAAP
Diluted Loss Per Share from Continuing Operations of $7.89 and
EBITDAR Loss of $134 Million(2)
Results Reflect After-Tax Costs of $690
Million Primarily Including Non-Cash Impairments of $266
Million(3), Non-Cash Deferred Tax Asset Valuation
Allowance of $366 Million, and Hospital Divestiture Costs of $47
Million(3)(4)
Core EBITDAR of $220 Million(2)
and Core Diluted EPS from Continuing Operations of
$0.05(2) in the Third Quarter
Third Quarter GAAP Operating Cash Flows of
$36 million; Core Operating Cash Flows of $30
Million(2)
Updates Full Year 2016 Outlook
Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND)
today announced its operating results for the third quarter ended
September 30, 2016.
Benjamin A. Breier, President and Chief Executive Officer of the
Company, commented, “We are taking proactive strategic steps to
position Kindred for long-term success against the backdrop of
dynamic changes in the healthcare services industry. Our plan to
exit the skilled nursing facility business, together with the
significant cost realignment initiative we are undertaking in
connection with the exit, are substantial steps forward in our
continuing effort to transform Kindred’s strategy and growth
profile to enhance shareholder value.”
Mr. Breier added, “Over the past few years we have dramatically
transformed the composition of Kindred, and our drivers of
profitability and growth. Following our exit of the skilled nursing
facility business and the associated cost realignment initiative,
Kindred’s earnings stream, cash flow generation and leverage
profile will be substantially improved, including significant
reductions of fixed costs such as rent and capital expenditures.
Over time, when complete, we expect approximately half of Kindred’s
earnings before interest and income taxes (“EBIT”) to come from
Kindred at Home, the nation’s largest home health, hospice and
community care provider, roughly one-quarter of Kindred’s EBIT to
come from our Long-Term Acute Care (“LTAC”) Hospital Division, and
the remaining approximately one-quarter of EBIT from Kindred’s
Rehabilitation Services Division, which includes one of the fastest
growing inpatient rehabilitation facilities (“IRF”) businesses in
the country.”
Plan to Exit the Skilled Nursing Facility Business
Mr. Breier continued, “Our strategic decision to exit the
skilled nursing facility business as an owner and operator is the
final step in a process that began years ago when Kindred operated
approximately 300 skilled nursing facilities. This decision will
reduce annual rent obligations by approximately $90 million and
annual capital expenditures by approximately $30 million. In
addition, Kindred will optimize its overhead structure by
eliminating approximately $70 million to $100 million(1) of
divisional and corporate overhead above the facility level, much of
which is associated with supporting our skilled nursing
facilities.”
____________
(1) See Forward-Looking Statements beginning on page 14. (2) See
reconciliation of generally accepted accounting principles (“GAAP”)
results to non-GAAP results beginning on page 14. As used herein,
“EBITDAR” means earnings before interest, income taxes,
depreciation, amortization and rent. (3) The income tax benefit
used to compute after-tax cost is before the deferred tax valuation
allowance is applied. (4) In connection with the previously
announced sale of twelve hospitals to a group of entities under the
name “Curahealth”, which are affiliates of a private investment
fund sponsored by Nautic Partners, LLC, on October 1, 2016 (the
“Curahealth Disposal”), the Company recorded a lease termination
fee of $51.8 million ($31.4 million net of income taxes) and loss
on sale of $8.1 million ($4.9 million net of income taxes) in the
third quarter of 2016. In addition, the Company closed three LTAC
hospitals in the third quarter and incurred facility closing and
other costs totaling $17.6 million ($10.7 million net of income
taxes).
LTAC Criteria
Mr. Breier continued, “In preparation for LTAC patient criteria,
during recent months we completed the strategic sale, swap or
closure of 20 LTAC hospitals, executing a critical component of our
multi-faceted criteria mitigation strategy. These actions leave
Kindred with a meaningfully reshaped portfolio of 82 LTAC
hospitals, with strategically reduced unused bed capacity in many
of the markets we serve.
“Effective September 1, 2016, all of our ongoing LTAC hospitals
were being reimbursed under the new criteria model. For the month
of September, approximately 86% of our ongoing Hospital Division
revenue came from Medicare compliant patients, managed care and
commercial patients, and patients from other payors such as
Medicaid. The remaining 14% of revenue was from Medicare
site-neutral patients. The unmitigated revenue impact of LTAC
criteria for the ongoing hospital portfolio in September was
approximately $8 million.
“After two years of preparation, and based on early feedback, we
are confident in our ability to successfully navigate through this
transition. We continue to expect that by the end of 2017, on a run
rate basis, we will mitigate roughly half of the impact of this
reimbursement change. We expect to have many more insights on these
trends and our experience with criteria once we complete our first
full quarter,” remarked Mr. Breier.
Continued Growth in other Business Lines
Mr. Breier continued, “We remain optimistic about the growth
opportunities in our home health, hospice, community care and IRF
businesses. During the quarter, we acquired a large home health,
hospice and community care business in Arkansas and continued to
work through integration activities in our Kindred at Home (“KAH”)
Division. We are pleased with the strong volume and revenue growth
in KAH as well as our Kindred Hospital Rehabilitation Services
(“KHRS”) business and will continue our efforts to expand these
businesses through organic growth, acquisitions and joint venture
arrangements.
“We also continue to make great progress in developing our
post-acute benefits management capabilities. Our future will be
driven by our ability to not only care for patients, but to manage
populations through a unique bundle of technology-enabled care
management capabilities. We believe these combined actions are
setting the foundation for a stronger Kindred as we drive effective
patient-centered care solutions and proactively address the
changing healthcare marketplace,” remarked Mr. Breier.
All financial and statistical information included in this press
release reflects the continuing operations of the Company’s
businesses for all periods presented unless otherwise
indicated.
Third Quarter Consolidated Results(1):
- Consolidated revenues were $1.8
billion, a 1.6% year-over-year increase, while the GAAP loss from
continuing operations was $671.3 million compared to a loss of $7.0
million in the same period in 2015. The increase in the GAAP loss
from continuing operations was primarily attributable to non-cash
goodwill and property impairment charges totaling
$324.3 million ($266.1 million(2) net of income taxes), a
non-cash deferred tax valuation allowance of $366.5 million and
restructuring charges related to the sale or closure of 15 LTAC
hospitals of $77.5 million ($47.0 million(2) net of income taxes).
Core EBITDAR declined 6.9% to $220.1 million compared to
$236.5 million in the same period in 2015, primarily due to
declines in average daily census in both the Nursing Center and
RehabCare business segments, lower Medicare revenue rates under
LTAC patient criteria, and Hospital Division closing costs and
labor pressures.
- GAAP operating cash flows were $36.0
million compared to $132.3 million for the same period a year ago.
Core operating cash flows were $30.3 million compared to $128.4
million for the same period a year ago. Core free cash flows were
$3.7 million compared to $82.3 million in the same period a
year ago. The decline in both GAAP and core operating and free cash
flows in the third quarter of 2016 was primarily attributable to
certain timing differences and other items increasing cash required
to fund working capital, much of which is expected to be
transitional in nature and recouped over the balance of 2016 and
into early 2017. Both GAAP and core operating and free cash flow
were also impacted in the third quarter by lower earnings.
____________
(1) See reconciliation of GAAP results to non-GAAP results
beginning on page 14. (2) The income tax benefit used to compute
after-tax cost is before the deferred tax valuation allowance is
applied.
Third Quarter Consolidated
Results(1)(Continued):
- GAAP diluted loss per share from
continuing operations was $7.89 as compared to $0.20 a year ago.
The increase in GAAP diluted loss per share from continuing
operations was primarily attributable to an increase in certain
charges in the third quarter of 2016. GAAP diluted loss per share
in the third quarter of 2016 includes after-tax costs of $689.9
million or $7.94 per diluted share of charges related to
impairments, deferred tax asset valuation allowance, restructuring,
transaction, integration, and research and development costs. GAAP
diluted loss per share in the third quarter of 2015 includes
$40.2 million ($37.4 million net of income taxes) or
$0.43 per diluted share of charges related to restructuring,
transaction, integration and litigation costs. Core diluted
earnings per share (“EPS”) from continuing operations was $0.05 as
compared to $0.23 a year ago. The decline in core diluted EPS was
attributable to the same factors discussed above that contributed
to a decline in core EBITDAR, plus a 3% increase in aggregate rent,
depreciation and amortization, and net interest expense.
- The Company recorded a $261.1 million
non-cash goodwill impairment charge in the third quarter to reflect
an adjustment to the carrying value of its Hospital Division
reporting unit. The Company also recorded a $24.9 million non-cash
property and equipment impairment charge primarily related to the
Nursing Center Division.
- The Company recorded a $366.5 million
non-cash deferred tax valuation allowance in the third quarter
based upon current expectations of GAAP and taxable losses in 2016
combined with cumulative years of historical GAAP and taxable
losses incurred primarily from restructuring and transactional
activities, refinancing fees and litigation settlements. This
non-cash charge is included in the third quarter income tax
provision and will have no impact on the Company’s ability to
utilize its net operating loss (“NOL”) carryforwards on a cash
basis as Kindred earns taxable income in future periods.
Third Quarter Segment Results(1)(2):
KAH, which comprises our home health, hospice, community care
and home-based primary care businesses, recorded third quarter
revenues that increased 5.5% over the prior year period to $638.5
million with home health episodic admissions growing 3.7% and
hospice average daily census growing 5.4% compared to the same
period last year. Segment EBITDAR (GAAP) increased 4.6% to $106.4
million as compared to $101.7 million and core EBITDAR increased
4.1% to $106.4 million compared to $102.2 million, both compared to
the prior year period. On a same-store basis, home health episodes
grew 6.9% and hospice admissions grew 8.3% over the prior year
period.
Kindred’s Hospital Division third quarter revenues declined 0.7%
from the prior year period to $575.3 million due to its full
entrance into LTAC patient criteria, and the closure of three LTAC
hospitals within the period. These declines were offset partially
by a 1% increase in same-hospital admissions and a 3.3% increase in
same-hospital commercial revenue rates. Segment EBITDAR (GAAP) in
the Hospital Division for the third quarter declined 13.9% to $82.8
million from $96.1 million a year ago, and core EBITDAR for
the third quarter declined 14.8% to $82.8 million from $97.1
million a year ago, both due primarily to LTAC patient criteria and
increases in labor costs. These results also reflect an unbudgeted
EBITDAR decline compared to expectations in the third quarter of
2016 of $3.2 million related to the operations of LTAC hospitals
acquired in a facility swap transaction in the second quarter of
2016, and $3.9 million related to the operations of three LTAC
hospitals closed in the third quarter of 2016.
Kindred Rehabilitation Services (“KRS”) Division, which
comprises our hospital-based rehabilitation segment, recorded third
quarter revenues that declined 2.0% from the prior year period to
$361.5 million. Segment EBITDAR (GAAP) for KRS increased 3.6% to
$58.7 million as compared to $56.7 million in the prior year period
and core EBITDAR increased 4.9% to $59.5 million compared to $56.7
million a year ago. Strong performance in the third quarter from
KHRS IRFs was offset by the continuing impact of previously
reported contract losses in RehabCare, which occurred primarily in
2015. The KHRS segment achieved strong revenue growth of 13.1%, and
segment EBITDAR (GAAP) and core EBITDAR grew 17.4% and 19.2%,
respectively, compared to the same period a year ago, with IRF
same-hospital discharges growing 5.9% during the quarter. RehabCare
revenues declined 12.3% to $192.5 million. RehabCare third quarter
segment EBITDAR (GAAP) and core EBITDAR both declined 36.4% to $9.3
million from $14.5 million a year ago.
____________
(1) See reconciliation of GAAP results to non-GAAP results
beginning on page 14. (2) See same-hospital and full segment data
on pages 9 through 13.
Third Quarter Segment
Results(1)(2)(Continued):
Kindred’s Nursing Center Division third quarter revenues
declined 0.1% to $270.3 million compared to the same period last
year. Segment EBITDAR (GAAP) and core EBITDAR both declined 16.7%
to $29.9 million compared to $35.9 million a year ago, as a result
of a 0.7% decline in average daily census, patient mix
deterioration and higher labor costs.
2016 Outlook
All forward-looking non-GAAP financial measures contained in
this section “2016 Outlook” are provided only on a non-GAAP basis.
This is due to the inherent difficulty of forecasting the timing or
amount of items that would be included in the most directly
comparable forward-looking GAAP financial measures. As a
result, reconciliation of the forward-looking non-GAAP financial
measures to GAAP financial measures is not available without
unreasonable effort and the Company is unable to address the
probable significance of the unavailable information.
The Company’s outlook excludes transaction costs, the effect of
any reimbursement changes, debt refinancing costs, severance,
retirement, retention, restructuring costs, litigation and related
contingency expense, integration costs, business interruption
settlements, research and development, any further acquisitions or
divestitures, any impairment charges, deferred tax asset valuation
allowance, any further issuances of common stock or any repurchases
of common stock.
Kindred today updated its outlook for 2016. Kindred expects:
- Annual revenues of approximately $7.2
billion (previously $7.2 billion to $7.3 billion).
- Core EBITDAR of $950 million to
$970 million (previously $970 million to $1.010 billion). Please
note that approximately $10 million of this adjustment was due to
items previously excluded from guidance.(3)
- Core diluted EPS from continuing
operations of $0.70 to $0.80 per share (previously $0.80 to $1.00
per share). Please note that approximately $0.03 per share of this
adjustment was due to items previously excluded from
guidance.(3)(4)
Mr. Breier concluded, “While our results for the third quarter
were within our guidance range, we are reducing our financial
outlook for the balance of 2016. Our change in expectations is
primarily impacted by significant headwinds facing the skilled
nursing facility business and labor cost challenges impacting both
the Company and the healthcare industry in general. Our exposure to
the challenges facing the nursing center industry is expected to
amount to between $40 million to $50 million of EBITDAR
compared to our operating plan for the year upon which our guidance
was based. Our decision to reduce guidance for the balance of 2016,
exit the skilled nursing facility business and substantially reduce
our overhead is directly related to these challenges.”
The Company will update its outlook for 2017 with its fourth
quarter earnings release in February 2017, which will reflect the
planned exit from the skilled nursing facility business and
associated cost realignment initiative.
Stephen D. Farber, Executive Vice President and Chief Financial
Officer of Kindred, noted, “We expect our full exit from the
skilled nursing facility business, upon completion, to be positive
for future cash flows. In the near term, we have previously
discussed our expectation that Kindred will generate roughly $300
million per year in core operating cash flows and approximately
half of that amount in core free cash flows. With our revised
earnings outlook for 2016, we would expect a relatively
proportionate adjustment to cash flows. We also expect a number of
timing-related working capital items to modestly impact Kindred’s
cash flows over the balance of the year and into early 2017.”
____________
(1) See reconciliation of GAAP results to non-GAAP results
beginning on page 14. (2) See same-hospital and full segment data
on pages 9 through 13. (3) Contributing to the reduction of 2016
outlook are two events (a) the Curahealth Disposal and reduced
hospital earnings, compared to the budget upon which previous
guidance was based, and (b) reimbursement rate reductions announced
by the Center for Medicare and Medicaid Services on August 2, 2016.
Each of these required a $5 million reduction in core EBITDAR
guidance and the latter required a $0.03 reduction in core diluted
EPS guidance. (4) The EPS estimate is based upon an estimated
weighted average annual diluted share count for 2016 of 87.5
million shares.
2016 Outlook (Continued)
Mr. Farber continued, “Every quarter we experience routine
working capital and initiative-related timing differences with cash
flows that should be expected as a matter of course by those that
follow and model the Company. In the third quarter these items
accounted for much of the difference in year-over-year cash flow
performance. For example, during the third quarter licensure
transfers related to recent acquisitions had a $16 million
temporary negative impact. These transfers are now complete and we
expect to process the billing backlog before the end of the year.
There are also frequent calendar-driven timing issues, such as an
extra payroll cycle in the third quarter compared to prior year,
which had a negative $30 million impact on cash flows this period,
and one less Medicare payment cycle during the third quarter
compared to the prior year, which had a negative impact on reported
LTAC collections of approximately $35 million. Additionally, during
the quarter two of our payors, one large commercial payor and one
state Medicaid payor, both had systems problems that slowed down
payment processing and increased accounts receivable in the third
quarter by approximately $13 million.”
Mr. Farber concluded, “Cash flow remains a core focus for
Kindred, and the non-cash deferred tax asset valuation allowance
charge this quarter will have no impact on our ability to utilize
our NOLs going forward as Kindred earns taxable income. Finally, we
ended the quarter with excellent liquidity, with approximately $160
million drawn on our $900 million asset-based revolving credit
facility.”
The Kindred Board of Directors declared a cash dividend of $0.12
per share on the Company’s common stock payable on December 9, 2016
to shareholders of record as of the close of business on November
21, 2016.
Conference Call
As previously announced, investors and the general public may
access a live webcast of the third quarter 2016 conference call
through a link on the Company’s website at
http://investors.kindredhealthcare.com. The conference call will be
held on November 8 at 9:00 a.m. (Eastern Time).
A telephone replay of the conference call will become available
at approximately 12:00 p.m. on November 8 by dialing
(719) 457-0820, access code: 6877746. The replay will be
available through November 18.
Forward-Looking Statements and Non-GAAP
Reconciliations
See page 14 for important disclosures regarding the Company’s
forward-looking statements and the non-GAAP financial
reconciliations that follow.
About Kindred Healthcare
Kindred Healthcare, Inc., a top-90 private employer in the
United States, is a FORTUNE 500 healthcare services company based
in Louisville, Kentucky with annual revenues of approximately $7.2
billion(1). As of October 1, 2016, Kindred through its subsidiaries
had approximately 102,200 employees providing healthcare services
in 2,702 locations in 46 states, including 82 LTAC hospitals, 19
inpatient rehabilitation hospitals, 91 nursing centers, 19
sub-acute units, 647 Kindred at Home home health, hospice and
non-medical home care sites of service, 104 inpatient
rehabilitation units (hospital-based) and contract rehabilitation
service businesses which served 1,740 non-affiliated sites of
service. Ranked as one of Fortune magazine’s Most Admired
Healthcare Companies for seven years, Kindred’s mission is to
promote healing, provide hope, preserve dignity and produce value
for each patient, resident, family member, customer, employee and
shareholder we serve. For more information, go to
www.kindredhealthcare.com. You can also follow us on Twitter and
Facebook.
____________
(1) Revenues based upon Kindred consolidated revenues for the
twelve months ended September 30, 2016.
KINDRED HEALTHCARE, INC.
Condensed Consolidated Statement of Operations
(Unaudited) (In thousands, except per share amounts)
Three months ended Nine months ended September
30, September 30, 2016 2015 2016
2015 Revenues
$ 1,793,527 $
1,764,516
$ 5,473,568 $ 5,273,958
Salaries, wages and benefits
957,644 922,140
2,812,812 2,704,920 Supplies
95,500 96,551
294,326 288,059 Rent
98,415 95,436
296,025
282,955 Other operating expenses
217,364 207,837
649,915 617,681 General and administrative expenses
310,407 307,500
998,559 1,043,986 Other income
(446 ) (650 )
(1,909 ) (1,699 )
Litigation contingency expense
- 31,462
2,840 130,387
Impairment charges
324,289 -
338,208 6,726
Restructuring charges
81,463 3,349
88,223 8,793
Depreciation and amortization
40,382 39,329
121,320
116,889 Interest expense
59,862 56,440
175,417
176,128 Investment income
(1,810 ) (432
)
(2,561 ) (2,203 )
2,183,070 1,758,962
5,773,175 5,372,622 Income (loss) from
continuing operations before income taxes
(389,543 )
5,554
(299,607 ) (98,664 ) Provision for income taxes
281,752 12,523
311,470 9,183 Loss from continuing
operations
(671,295 ) (6,969 )
(611,077
) (107,847 ) Discontinued operations, net of income taxes:
Income (loss) from operations
(12 ) 2,269
2,422 (1,744 ) Gain on divestiture of operations
- -
179 983
Income (loss) from discontinued operations
(12
) 2,269
2,601 (761
) Net loss
(671,307 ) (4,700 )
(608,476
) (108,608 ) (Earnings) loss attributable to noncontrolling
interests: Continuing operations
(14,305 ) (9,900 )
(40,341 ) (30,482 ) Discontinued operations
(1 ) 1
(6 )
32
(14,306 ) (9,899 )
(40,347 ) (30,450 ) Loss attributable to
Kindred
$ (685,613 ) $ (14,599 )
$
(648,823 ) $ (139,058 ) Amounts attributable
to Kindred stockholders: Loss from continuing operations
$
(685,600 ) $ (16,869 )
$ (651,418
) $ (138,329 ) Income (loss) from discontinued operations
(13 ) 2,270
2,595
(729 ) Net loss
$ (685,613 ) $
(14,599 )
$ (648,823 ) $ (139,058 )
Loss per common share: Basic: Loss from continuing operations
$ (7.89 ) $ (0.20 )
$ (7.51
) $ (1.65 ) Discontinued operations: Income (loss) from
operations
- 0.03
0.03 (0.02 ) Gain on divestiture of
operations
- -
-
0.01 Income (loss) from discontinued
operations
- 0.03
0.03 (0.01 ) Net loss
$ (7.89
) $ (0.17 )
$ (7.48 ) $ (1.66 )
Diluted: Loss from continuing operations
$ (7.89
) $ (0.20 )
$ (7.51 ) $ (1.65 )
Discontinued operations: Income (loss) from operations
-
0.03
0.03 (0.02 ) Gain on divestiture of operations
- -
- 0.01
Income (loss) from discontinued operations
-
0.03
0.03 (0.01 )
Net loss
$ (7.89 ) $ (0.17 )
$
(7.48 ) $ (1.66 ) Shares used in computing
loss per common share: Basic
86,869 86,184
86,766
83,960 Diluted
86,869 86,184
86,766 83,960
Cash dividends declared and paid per common share
$
0.12 $ 0.12
$ 0.36 $ 0.36
KINDRED HEALTHCARE, INC. Condensed Consolidated Balance
Sheet (Unaudited) (In thousands, except per share
amounts)
September 30,
December 31, 2016 2015 ASSETS Current
assets: Cash and cash equivalents
$ 139,430 $ 98,758
Insurance subsidiary investments
105,346 106,638 Accounts
receivable less allowance for loss
1,266,545 1,194,868
Inventories
25,262 27,791 Income taxes
12,416 11,790
Other
94,876 61,054
1,643,875 1,500,899 Property and equipment
2,070,421 2,162,398 Accumulated depreciation
(1,192,870 ) (1,190,402 )
877,551
971,996 Goodwill
2,422,473 2,669,810 Intangible
assets less accumulated amortization
804,602 755,655
Insurance subsidiary investments
195,517 204,498 Deferred
tax assets
- 104,130 Acquisition deposit
- 18,489
Other
283,322 242,782 Total
assets
$ 6,227,340 $ 6,468,259
LIABILITIES AND EQUITY Current liabilities: Accounts payable
$ 203,426 $ 187,061 Salaries, wages and other
compensation
390,743 404,925 Due to third party payors
57,945 36,251 Professional liability risks
61,036
64,099 Other accrued liabilities
280,305 394,246 Long-term
debt due within one year
27,889 24,630
1,021,344 1,111,212 Long-term debt
3,316,174 3,086,348 Professional liability risks
283,048 263,273 Deferred tax liabilities
200,334 -
Deferred credits and other liabilities
354,246 301,379
Equity: Stockholders' equity:
Common stock, $0.25 par value; authorized
175,000 shares; issued 85,187 shares - September 30, 2016 and
83,792 shares - December 31, 2015
21,297 20,948 Capital in excess of par value
1,717,165 1,737,747 Accumulated other comprehensive loss
(4,334 ) (2,632 ) Accumulated deficit
(905,137 ) (256,209 )
828,991 1,499,854
Noncontrolling interests
223,203
206,193 Total equity
1,052,194
1,706,047 Total liabilities and equity
$
6,227,340 $ 6,468,259
KINDRED HEALTHCARE,
INC. Condensed Consolidated Statement of Cash Flows
(Unaudited) (In thousands)
Three months ended
Nine months ended September 30, September 30,
2016 2015 2016 2015 Cash flows from
operating activities: Net loss
$ (671,307 ) $
(4,700 )
$ (608,476 ) $ (108,608 )
Adjustments to reconcile net loss to net
cash provided by operating activities:
Depreciation expense
34,914 31,867
103,306 95,325
Amortization of intangible assets
5,468 7,728
18,251
22,196 Amortization of stock-based compensation costs
3,015
3,194
13,058 15,764 Amortization of deferred financing costs
3,987 3,554
11,262 10,155 Payment of capitalized
lender fees related to debt issuance
(42 ) -
(7,375 ) (28,012 ) Provision for doubtful accounts
10,009 11,014
30,955 29,817 Deferred income taxes
(84,173 ) 3,556
(54,875 ) (894 )
Impairment charges
324,289 -
338,208 6,726 Gain on
divestiture of discontinued operations
- -
(179
) (983 ) Other
6,303 3,485
7,262 10,457 Change
in operating assets and liabilities: Accounts receivable
(42,832 ) 25,990
(143,953 ) (13,399 )
Inventories and other assets
11,871 8,767
(3,522
) 44,181 Accounts payable
11,995 (353 )
24,451
(12,788 ) Income taxes
364,925 37,491
365,705 33,646
Due to third party payors
24,809 15,008
20,317 (3,965
) Other accrued liabilities
32,851
(14,311 )
(76,347 ) (6,551 ) Net cash
provided by operating activities
36,082
132,290
38,048 93,067
Cash flows from investing activities: Routine capital
expenditures
(21,873 ) (35,422 )
(68,703
) (80,691 ) Development capital expenditures
(8,386
) (5,760 )
(27,112 ) (12,066 ) Acquisitions,
net of cash acquired
(49,329 ) (2,002 )
(77,040 ) (663,757 ) Acquisition deposits
- -
18,489 195,000 Sale of assets
3,739 3,884
4,962 7,061 Proceeds from senior unsecured notes offering
held in escrow
- -
- 1,350,000 Interest in escrow for
senior unsecured notes
- -
- 23,438 Purchase of
insurance subsidiary investments
(22,427 ) (16,357 )
(75,422 ) (59,186 ) Sale of insurance subsidiary
investments
31,875 15,987
78,478 50,780 Net change in
insurance subsidiary cash and cash equivalents
(14,680
) (2,633 )
8,479 (8,396 ) Proceeds from note
receivable
- 25,000
- 25,000 Net change in other
investments
51 176
(33,347 ) 375 Other
(150 ) 1,383
(1,277
) 590 Net cash provided by (used in) investing
activities
(81,180 ) (15,744 )
(172,493 ) 828,148 Cash flows
from financing activities: Proceeds from borrowings under revolving
credit
489,200 259,700
1,267,200 1,414,850 Repayment
of borrowings under revolving credit
(388,100 )
(349,700 )
(1,215,800 ) (1,319,850 ) Proceeds from
issuance of term loan, net of discount
- -
198,100
199,000 Proceeds from other long-term debt
- -
750 -
Repayment of Gentiva debt
- -
- (1,177,363 )
Repayment of term loan
(3,508 ) (3,003 )
(10,019 ) (9,008 ) Repayment of other long-term debt
(276 ) (500 )
(826 ) (1,400 ) Payment
of deferred financing costs
(50 ) (301 )
(342
) (3,284 ) Issuance of common stock in connection with
employee benefit plans
- 329
- 534
Payment of costs associated with issuance
of common stock and tangible equity units
- -
- (915 ) Payment of dividend for mandatory
redeemable preferred stock
(2,904 ) (2,703 )
(8,558 ) (8,135 ) Dividends paid
(10,224
) (10,065 )
(30,517 ) (30,067 ) Contributions
made by noncontrolling interests
4,993 1,492
11,261
1,492 Distributions to noncontrolling interests
(4,694
) (10,685 )
(35,240 ) (31,823 ) Purchase of
noncontrolling interests
- -
(1,000 ) - Other
35 245
108
1,457 Net cash provided by (used in) financing
activities
84,472 (115,191 )
175,117 (964,512 ) Change in cash and cash
equivalents
39,374 1,355
40,672 (43,297 ) Cash and
cash equivalents at beginning of period
100,056
119,536
98,758
164,188 Cash and cash equivalents at end of period
$
139,430 $ 120,891
$ 139,430
$ 120,891
KINDRED HEALTHCARE,
INC. Condensed Consolidated and Business Segment Data
(Unaudited) (In thousands, except per share amounts)
Third quarter
2015 Quarters 2016 Quarters % change v.
First Second Third Fourth First
Second Third prior year Condensed
consolidated income statement data: GAAP presentation:
Revenues $ 1,675,967 $ 1,833,475 $ 1,764,516 $ 1,780,949 $
1,837,971 $ 1,842,070 $ 1,793,527 1.6 Operating expenses 1,645,791
1,584,873 1,568,189 1,583,985 1,604,855 1,591,898 1,986,221 26.7
Rent 91,788 95,731 95,436 96,934 97,517 100,093 98,415 3.1
Depreciation and amortization 38,935 38,625 39,329 40,362 40,681
40,257 40,382 2.7 Interest, net 61,777 56,140
56,008 55,664 57,245
57,559 58,052 3.6
Income (loss) from continuing operations
before income taxes
(162,324 ) 58,106 5,554 4,004 37,673 52,263 (389,543 ) NM Provision
(benefit) for income taxes (27,736 ) 24,396
12,523 (51,980 ) 11,836
17,882 281,752 NM Income (loss) from
continuing operations (134,588 ) 33,710 (6,969 ) 55,984 25,837
34,381 (671,295 ) NM Noncontrolling interests (8,847 )
(11,735 ) (9,900 ) (12,082 ) (12,514 )
(13,522 ) (14,305 ) 44.5 Net income (loss)
attributable to Kindred $ (143,435 ) $ 21,975 $ (16,869 ) $
43,902 $ 13,323 $ 20,859 $ (685,600 ) NM
Diluted EPS $ (1.80 ) $ 0.25 $ (0.20 ) $ 0.50 $ 0.15 $ 0.23
$ (7.89 ) NM Diluted shares 79,575 86,402 86,184 87,232 87,249
87,500 86,869 0.8
Core presentation (a): EBITDAR $
234,211 $ 261,800 $ 236,477 $ 247,839 $ 246,834 $ 267,895 $ 220,075
(6.9 ) Rent 91,199 95,528 95,436 96,934 97,517 100,093 98,069 2.8
Interest, net 44,346 56,140 56,008 55,664 57,245 57,559 58,052 3.6
Provision for income taxes 22,466 25,721 15,298 13,758 16,546
21,417 4,639 (69.7 ) Net income attributable to Kindred 28,418
34,051 20,506 29,039 22,331 34,031 4,340 (78.8 ) Core
diluted EPS $ 0.34 $ 0.39 $ 0.23 $ 0.33 $ 0.25 $ 0.38 $ 0.05 (78.3
) Diluted shares 82,422 86,402 86,892 87,232 87,249 87,500 87,529
0.7
Revenues by segment: Hospital division $ 640,483
$ 627,206 $ 579,497 $ 593,593 $ 643,299 $ 633,695 $ 575,323 (0.7 )
Kindred at Home: Home health 300,867 427,820 424,054 425,759
430,035 438,556 449,958 6.1 Hospice 119,057
178,005 181,140 178,325
176,426 185,641 188,575 4.1
419,924 605,825 605,194 604,084 606,461 624,197 638,533 5.5 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
151,564 152,544 149,435 155,579 165,774 169,815 169,018 13.1
RehabCare 252,595 236,791
219,518 206,582 204,248
196,075 192,480 (12.3 ) 404,159 389,335
368,953 362,161 370,022 365,890 361,498 (2.0 ) Nursing center
division 274,308 273,870 270,510
273,387 272,227 272,395
270,259 (0.1 ) 1,738,874 1,896,236 1,824,154
1,833,225 1,892,009 1,896,177 1,845,613 1.2 Eliminations
(62,907 ) (62,761 ) (59,638 ) (52,276 )
(54,038 ) (54,107 ) (52,086 ) (12.7 ) $ 1,675,967
$ 1,833,475 $ 1,764,516 $ 1,780,949 $
1,837,971 $ 1,842,070 $ 1,793,527 1.6
__________
NM = not meaningful
(a) See reconciliation of GAAP results to
non-GAAP results beginning on page 14.
KINDRED HEALTHCARE, INC. Condensed
Consolidated and Business Segment Data (Continued)
(Unaudited) (In thousands, except statistics)
Third quarter 2015
Quarters 2016 Quarters % change v. First
Second Third Fourth First Second
Third prior year Segment EBITDAR (GAAP) (a):
Hospital division $ 134,111 $ 131,532 $ 96,108 $ 116,454 $ 135,495
$ 125,932 $ 82,752 (13.9 ) Kindred at Home: Home health 46,798
72,917 67,682 68,776 66,941 76,030 75,073 10.9 Hospice
16,996 27,887 34,025
30,212 24,866 31,329
31,326 (7.9 ) 63,794 100,804 101,707 98,988 91,807 107,359
106,399 4.6 Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 44,564 44,531 42,141 44,891 47,870 50,469
49,470 17.4 RehabCare 15,708 14,681
14,544 (1,118 ) 11,987
13,269 9,248 (36.4 ) 60,272 59,212 56,685
43,773 59,857 63,738 58,718 3.6 Nursing center division 36,963
39,877 35,923 36,601 30,100 33,662 29,922 (16.7 )
Core EBITDAR by segment (b): Hospital division $ 134,786 $
131,532 $ 97,128 $ 117,675 $ 135,495 $ 125,932 $ 82,752 (14.8 )
Kindred at Home: Home health 46,798 72,917 68,155 68,826 65,803
75,859 75,073 10.2 Hospice 16,996 27,887
34,025 30,212 24,866
31,329 31,326 (7.9 ) 63,794
100,804 102,180 99,038 90,669 107,188 106,399 4.1 Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
44,564 44,531 42,141 45,098 47,870 50,469 50,217 19.2 RehabCare
16,493 14,681 14,544
11,858 11,987 13,269
9,248 (36.4 ) 61,057 59,212 56,685 56,956 59,857
63,738 59,465 4.9 Nursing center division 36,963 40,461 35,923
36,601 30,100 33,662 29,922 (16.7 ) Support center (62,389 )
(70,209 ) (55,439 ) (c) (62,431 )
(69,287 ) (62,625 ) (58,463 ) (c) 5.5 $ 234,211
$ 261,800 $ 236,477 $ 247,839 $ 246,834
$ 267,895 $ 220,075 (6.9 )
EBITDAR
margin by segment: Hospital division 20.9 21.0 16.6 19.6 21.1
19.9 14.4 (2.2 ) Kindred at Home: Home health 15.6 17.0 16.0 16.2
15.6 17.3 16.7 0.7 Hospice 14.3 15.7 18.8 16.9 14.1 16.9 16.6 (2.2
) Kindred at Home 15.2 16.6 16.8 16.4 15.1 17.2 16.7 (0.1 ) Kindred
Rehabilitation Services: Kindred Hospital Rehabilitation Services
29.4 29.2 28.2 28.9 28.9 29.7 29.3 1.1 RehabCare 6.2 6.2 6.6 (0.5 )
5.9 6.8 4.8 (1.8 ) Kindred Rehabilitation Services 14.9 15.2 15.4
12.1 16.2 17.4 16.2 0.8 Nursing center division 13.5 14.6 13.3 13.4
11.1 12.4 11.1 (2.2 )
Core EBITDAR margin by segment:
Hospital division 21.0 21.0 16.8 19.8 21.1 19.9 14.4 (2.4 ) Kindred
at Home: Home health 15.6 17.0 16.1 16.2 15.3 17.3 16.7 0.6 Hospice
14.3 15.7 18.8 16.9 14.1 16.9 16.6 (2.2 ) Kindred at Home 15.2 16.6
16.9 16.4 15.0 17.2 16.7 (0.2 ) Kindred Rehabilitation Services:
Kindred Hospital Rehabilitation Services 29.4 29.2 28.2 29.0 28.9
29.7 29.7 1.5 RehabCare 6.5 6.2 6.6 5.7 5.9 6.8 4.8 (1.8 ) Kindred
Rehabilitation Services 15.1 15.2 15.4 15.7 16.2 17.4 16.4 1.0
Nursing center division 13.5 14.8 13.3 13.4 11.1 12.4 11.1 (2.2 )
Consolidated 14.0 14.3 13.4 13.9 13.4 14.5 12.3 (1.1 )
__________
(a) Segment EBITDAR includes
reclassification of restructuring charges from segment EBITDAR to
the new consolidated statement of operations caption, Restructuring
charges, for all historical periods.
(b) See reconciliation of GAAP results to
non-GAAP results beginning on page 14.
(c) Includes changes in estimate of $9
million and $4 million for the third quarters of 2015 and 2016,
respectively, to lower incentive compensation costs recorded in
prior periods.
KINDRED
HEALTHCARE, INC. Condensed Business Segment Data
(Continued) (Unaudited) Third quarter
2015 Quarters 2016 Quarters % change v.
First Second Third Fourth First
Second Third prior year Hospital
division: End of period data: Number of transitional care
hospitals 97 96 95 95 95 97 94 Number of licensed beds 7,147 7,124
7,094 7,094 7,089 7,067 6,890 Revenue mix %: Medicare 56.8 55.2
57.1 57.3 57.8 55.5 54.6 Medicaid 5.5 5.3 5.3 5.1 4.2 4.2 4.0
Medicare Advantage 11.9 11.6 10.8 11.1 11.5 12.0 12.1 Medicaid
Managed 4.7 5.6 6.1 6.2 5.6 6.3 7.3 Commercial insurance and other
21.1 22.3 20.7 20.3 20.9 22.0 22.0 Admissions: Medicare 8,775 8,267
7,976 8,169 8,919 8,253 7,861 (1.4 ) Medicaid 610 610 556 520 463
386 375 (32.6 ) Medicare Advantage 1,555 1,352 1,212 1,304 1,453
1,382 1,327 9.5 Medicaid Managed 643 675 646 612 733 768 861 33.3
Commercial insurance and other 1,868 1,815
1,763 1,701 1,871 1,807 1,727 (2.0 )
13,451 12,719 12,153 12,306
13,439 12,596 12,151 - Patient days: Medicare 228,483
218,577 210,870 210,409 229,004 219,013 202,482 (4.0 ) Medicaid
28,663 25,213 23,167 21,795 21,134 19,409 16,781 (27.6 ) Medicare
Advantage 48,448 44,740 39,585 41,079 45,760 47,697 43,241 9.2
Medicaid Managed 22,013 24,833 24,412 24,802 25,341 27,267 28,534
16.9 Commercial insurance and other 62,241 62,922
58,631 57,321 62,769 63,009
59,856 2.1 389,848 376,285 356,665
355,406 384,008 376,395 350,894 (1.6 ) Average
length of stay: Medicare 26.0 26.4 26.4 25.8 25.7 26.5 25.8 (2.3 )
Medicaid 47.0 41.3 41.7 41.9 45.6 50.3 44.7 7.2 Medicare Advantage
31.2 33.1 32.7 31.5 31.5 34.5 32.6 (0.3 ) Medicaid Managed 34.2
36.8 37.8 40.5 34.6 35.5 33.1 (12.4 ) Commercial insurance and
other 33.3 34.7 33.3 33.7 33.5 34.9 34.7 4.2 Weighted average 29.0
29.6 29.3 28.9 28.6 29.9 28.9 (1.4 ) Revenues per admission:
Medicare $ 41,483 $ 41,892 $ 41,451 $ 41,656 $ 41,717 $ 42,579 $
39,945 (3.6 ) Medicaid 57,594 54,795 55,415 57,724 57,928 69,797
61,338 10.7 Medicare Advantage 48,908 53,578 51,495 50,680 51,080
55,105 52,363 1.7 Medicaid Managed 46,740 51,950 54,976 60,263
49,287 51,696 48,631 (11.5 ) Commercial insurance and other 72,395
77,110 68,151 70,735 71,651 77,193 73,515 7.9 Weighted average
47,616 49,312 47,683 48,236 47,868 50,309 47,348 (0.7 ) Revenues
per patient day: Medicare $ 1,593 $ 1,584 $ 1,568 $ 1,617 $ 1,625 $
1,605 $ 1,551 (1.1 ) Medicaid 1,226 1,326 1,330 1,377 1,269 1,388
1,371 3.1 Medicare Advantage 1,570 1,619 1,577 1,609 1,622 1,597
1,607 1.9 Medicaid Managed 1,365 1,412 1,455 1,487 1,426 1,456
1,467 0.8 Commercial insurance and other 2,173 2,224 2,049 2,099
2,136 2,214 2,121 3.5 Weighted average 1,643 1,667 1,625 1,670
1,675 1,684 1,640 0.9
Medicare case mix index (discharged
patients only)
1.166 1.163 1.150 1.164 1.163 1.179 1.172 1.9 Average daily census
4,332 4,135 3,877 3,863 4,220 4,136 3,814 (1.6 ) Occupancy % 69.2
66.1 62.2 62.2 68.0 67.5 61.6 (1.0 ) Same-hospital data: Revenues
($ 000s) (a) $ 634,975 $ 605,410 $ 555,282 $ 571,925 $ 643,413 $
619,427 $ 556,091 0.1 Admissions: Medicare 8,652 8,031 7,659 7,933
8,919 8,083 7,571 (1.1 ) Medicaid 602 557 508 454 463 371 371 (27.0
) Medicare Advantage 1,546 1,299 1,166 1,238 1,453 1,339 1,292 10.8
Medicaid Managed 640 640 619 590 733 761 861 39.1 Commercial
insurance and other 1,840 1,746 1,680
1,624 1,871 1,751 1,658 (1.3 ) 13,280
12,273 11,632 11,839 13,439
12,305 11,753 1.0 Patient days: Medicare 225,992 212,221
202,690 204,128 229,004 214,629 194,857 (3.9 ) Medicaid 28,458
22,999 21,203 19,481 21,134 18,340 16,467 (22.3 ) Medicare
Advantage 48,276 42,863 37,272 39,122 45,760 46,522 41,955 12.6
Medicaid Managed 21,933 23,722 23,329 24,136 25,341 26,795 28,526
22.3 Commercial insurance and other 61,715 60,559
56,377 54,899 62,769 60,984
57,168 1.4 386,374 362,364 340,871
341,766 384,008 367,270 338,973 (0.6 ) Total
average length of stay 29.1 29.5 29.3 28.9 28.6 29.8 28.8 (1.7 )
Total revenues per patient day $ 1,643 $ 1,671 $ 1,629 $ 1,673 $
1,676 $ 1,687 $ 1,641 0.7
__________
(a) See reconciliation of same-hospital
revenues to reported revenues for the Hospital Division on page
17.
KINDRED
HEALTHCARE, INC. Condensed Business Segment Data
(Continued) (Unaudited) Third quarter
2015 Quarters 2016 Quarters % change v.
First Second Third Fourth First
Second Third prior year Pro forma hospital
data (a): End of period data: Number of transitional care
hospitals 82 82 82 82 82 82 82 Number of licensed beds 6,112 6,112
6,112 6,112 6,107 6,107 6,107 Revenue mix %: Medicare 57.3 55.5
57.7 57.7 57.9 55.3 54.2 Medicaid 4.9 4.7 4.8 4.5 3.9 3.9 3.6
Medicare Advantage 11.6 11.4 10.4 11.1 11.4 11.9 12.4 Medicaid
Managed 4.7 5.6 6.1 6.2 5.6 6.4 7.6 Commercial insurance and other
21.5 22.8 21.0 20.5 21.2 22.5 22.2 Admissions: Medicare 7,813 7,382
7,192 7,385 7,989 7,372 7,084 (1.5 ) Medicaid 530 548 511 447 430
358 343 (32.9 ) Medicare Advantage 1,330 1,143 1,065 1,123 1,261
1,198 1,188 11.5 Medicaid Managed 562 609 572 547 632 702 792 38.5
Commercial insurance and other 1,625 1,576
1,524 1,474 1,642 1,604 1,504 (1.3 )
11,860 11,258 10,864 10,976
11,954 11,234 10,911 0.4 Patient days: Medicare
204,423 195,427 190,223 190,718 204,796 194,955 181,518 (4.6 )
Medicaid 21,489 18,559 17,272 15,357 15,470 14,053 12,085 (30.0 )
Medicare Advantage 41,908 38,440 33,795 36,305 39,995 42,045 39,646
17.3 Medicaid Managed 19,537 22,351 21,700 22,063 22,421 24,893
26,698 23.0 Commercial insurance and other 54,988
54,697 51,485 50,779 55,455 55,653
53,015 3.0 342,345 329,474 314,475
315,222 338,137 331,599 312,962 (0.5 )
Average length of stay: Medicare 26.2 26.5 26.4 25.8 25.6 26.4 25.6
(3.0 ) Medicaid 40.5 33.9 33.8 34.4 36.0 39.3 35.2 4.1 Medicare
Advantage 31.5 33.6 31.7 32.3 31.7 35.1 33.4 5.4 Medicaid Managed
34.8 36.7 37.9 40.3 35.5 35.5 33.7 (11.1 ) Commercial insurance and
other 33.8 34.7 33.8 34.4 33.8 34.7 35.2 4.1 Weighted average 28.9
29.3 28.9 28.7 28.3 29.5 28.7 (0.7 ) Revenues per admission:
Medicare $ 41,885 $ 42,228 $ 41,877 $ 41,948 $ 41,912 $ 42,845 $
39,694 (5.2 ) Medicaid 52,950 48,186 49,075 53,935 51,710 62,187
54,801 11.7 Medicare Advantage 49,940 56,232 51,048 53,235 52,084
56,517 54,072 5.9 Medicaid Managed 48,002 52,017 55,653 61,296
51,511 52,419 50,027 (10.1 ) Commercial insurance and other 75,632
81,332 71,996 74,530 74,752 80,026 76,737 6.6 Weighted average
48,197 49,944 48,065 48,931 48,356 50,827 47,591 (1.0 ) Revenues
per patient day: Medicare $ 1,601 $ 1,595 $ 1,583 $ 1,624 $ 1,635 $
1,620 $ 1,549 (2.1 ) Medicaid 1,306 1,423 1,452 1,570 1,437 1,584
1,555 7.1 Medicare Advantage 1,585 1,672 1,609 1,647 1,642 1,610
1,620 0.7 Medicaid Managed 1,381 1,417 1,467 1,520 1,452 1,478
1,484 1.2 Commercial insurance and other 2,235 2,343 2,131 2,163
2,213 2,306 2,177 2.2 Weighted average 1,670 1,707 1,660 1,704
1,709 1,722 1,659 (0.1 ) Average daily census 3,804 3,621
3,418 3,426 3,716 3,644 3,402 (0.5 )
__________
(a) All historical statistics have been
adjusted to present the ongoing hospital division portfolio.
KINDRED HEALTHCARE, INC. Condensed Business
Segment Data (Continued) (Unaudited)
Third quarter 2015
Quarters 2016 Quarters % change v. First
Second Third Fourth First Second
Third prior year
Kindred at Home (data combined to
include Kindred and Gentiva for each historical period):
Home Health: Sites of service (at end of period) 415 411 388 373
384 384 395 Revenue mix %: Medicare 80.9 80.4 80.0 80.0 79.8 79.3
78.1 Medicaid 2.1 2.1 2.1 2.1 2.1 2.1 2.5 Commercial and other 7.3
7.9 8.2 8.5 8.4 8.2 8.6 Commercial paid at episodic rates 9.7 9.6
9.7 9.4 9.7 10.4 10.8 Episodic revenues ($ 000s) $ 308,317 $
324,027 $ 319,820 $ 320,698 $ 325,821 $ 332,193 $ 332,562 4.0 Total
episodic admissions 69,936 67,808 66,753 66,157 71,426 70,212
69,219 3.7 Medicare episodic admissions 61,186 59,394 58,479 57,804
62,011 60,730 59,823 2.3 Total episodes 110,980 109,599 108,519
108,300 113,887 113,278 113,256 4.4 Episodes per admission 1.59
1.62 1.63 1.64 1.59 1.61 1.64 0.6 Revenue per episode $ 2,778 $
2,956 $ 2,947 $ 2,961 $ 2,861 $ 2,933 $ 2,936 (0.4 ) Hospice: Sites
of service (at end of period) 190 185 181 175 177 177 185
Admissions 13,164 12,574 12,091 12,129 13,234 13,149 12,916 6.8
Average length of stay 95 93 101 100 92 91 98 (3.0 ) Patient days
1,150,841 1,190,604 1,211,291 1,185,330 1,183,908 1,238,584
1,277,125 5.4 Revenue per patient day $ 151 $ 150 $ 150 $ 150 $ 149
$ 150 $ 148 (1.3 ) Average daily census 12,787 13,084 13,166 12,884
13,010 13,611 13,882 5.4
Community Care and other revenues
(included in Home Health business segment) ($ 000s)
$ 65,530 $ 67,647 $ 67,338 $ 67,684 $ 66,305 $ 68,229 $ 75,978 12.8
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services: Freestanding IRFs: End of period data:
Number of IRFs 16 16 18 18 19 19 19 Number of licensed beds 829 829
919 919 969 969 969 Discharges (a) 3,806 3,927 3,941 4,317 4,448
4,646 4,644 17.8 Same-hospital discharges (a) 3,806 3,927 3,842
4,040 4,016 4,089 4,069 5.9 Occupancy % (a) 73.2 71.5 68.7 68.0
70.6 70.6 68.8 0.1 Average length of stay (a) 13.7 13.1 13.2 12.7
13.2 12.9 12.7 (3.8 ) Revenue per discharge (a) $ 19,517 $ 19,325 $
18,992 $ 18,640 $ 19,731 $ 19,318 $ 19,599 3.2 Contract services:
Sites of service (at end of period): Inpatient rehabilitation units
100 99 101 100 104 105 104 LTAC hospitals 120 120 119 119 119 121
120 Sub-acute units 8 8 7 7 7 7 7 Outpatient units 138
139 135 130 139 138 139
366 366 362 356 369 371
370 Revenue per site $ 211,151 $ 209,436 $ 206,041 $
210,978 $ 211,417 $ 215,798 $ 210,810 2.3 RehabCare: Sites
of service (at end of period) 1,829 1,789 1,821 1,798 1,767 1,759
1,754 Revenue per site $ 138,106 $ 132,359 $ 120,548 $ 114,896 $
115,590 $ 111,470 $ 109,738 (9.0 )
Nursing center
division: End of period data: Number of nursing centers 90 90
90 90 92 92 91 Number of licensed beds 11,535 11,535 11,535 11,535
11,815 11,815 11,568 Admissions (b) 10,376 9,831 9,558 9,237 9,815
9,480 9,698 1.5 Medicare average length of stay (b) 28.9 28.9 28.5
28.4 28.2 28.4 27.4 (3.9 ) Patient days (b) 861,278 852,691 851,332
845,924 846,578 842,681 845,037 (0.7 ) Revenues per patient day (b)
$ 319 $ 321 $ 318 $ 323 $ 322 $ 323 $ 320 0.6 Average daily census
(b) 9,570 9,370 9,254 9,195 9,303 9,260 9,185 (0.7 ) Occupancy %
(b) 81.3 79.6 78.6 78.1 77.3 76.7 77.5 (1.4 )
__________
(a) Excludes non-consolidating IRF.
(b) Excludes managed facilities.
Forward-Looking Statements This
earnings release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements include, but are not limited to,
all statements regarding the Company's ability to exit the skilled
nursing facility business discussed herein, as well as the
Company's ability to realize the anticipated benefits, cost savings
and strategic gains from this initiative, all statements regarding
the Company’s expected future financial position, results of
operations, cash flows, dividends, financing plans, business
strategy, budgets, capital expenditures, competitive positions,
growth opportunities, plans and objectives of management,
government investigations, regulatory matters, and statements
containing the words such as “anticipate,” “approximate,”
“believe,” “plan,” “estimate,” “expect,” “project,” “could,”
“would,” “should,” “will,” “intend,” “may,” “potential,” “upside,”
and other similar expressions. Statements in this earnings release
concerning the Company’s business outlook or future economic
performance, anticipated profitability, revenues, expenses,
dividends or other financial items, product or services line
growth, and expected outcome of government investigations and other
regulatory matters, together with other statements that are not
historical facts, are forward-looking statements that are estimates
reflecting the best judgment of the Company based upon currently
available information. Such forward-looking statements are
inherently uncertain, and stockholders and other potential
investors must recognize that actual results may differ materially
from the Company’s expectations as a result of a variety of
factors. Such forward-looking statements are based upon
management’s current expectations and include known and unknown
risks, uncertainties and other factors, many of which the Company
is unable to predict or control, that may cause the Company’s
actual results, performance or plans to differ materially from any
future results, performance or plans expressed or implied by such
forward-looking statements. These statements involve risks,
uncertainties and other factors detailed from time to time in the
Company’s Annual Report on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K filed with the Securities and
Exchange Commission. Many of these factors are beyond the
Company’s control. The Company cautions investors that any
forward-looking statements made by the Company are not guarantees
of future performance. The Company disclaims any obligation to
update any such factors or to announce publicly the results of any
revisions to any of the forward-looking statements to reflect
future events or developments.
Non-GAAP Measurements
In addition to the results provided in accordance with GAAP,
the Company has provided information in this earnings release to
compute certain non-GAAP measures. The use of these non-GAAP
measures are not intended to replace the presentation of the
Company’s financial results in accordance with GAAP.
Reconciliations of these non-GAAP measures to the most directly
comparable GAAP measures are included in the following pages of
this earnings release. EBITDAR: The Company defines EBITDAR
as earnings before interest, income taxes, depreciation,
amortization and rent, and believes that the presentation of
EBITDAR is useful to the investors because creditors, securities
analysts and investors use EBITDAR as a measure of earnings used to
compare the performance of companies in the healthcare industry
before consideration of the capital structure of fixed assets and
financing costs, which can vary significantly among companies.
For each of the Company’s segments, EBITDAR is a measure of
performance used by the Company’s chief operating decision makers
in accordance with “Accounting Standard Codification 280—Segment
Reporting.” In this context, the Company defines segment EBITDAR as
earnings before interest, income taxes, depreciation, amortization,
and rent, excluding litigation contingency expense, impairment
charges, restructuring charges, transaction costs, and the
allocation of support center overhead. Core Operating
Results: The Company calculates core operating results, including
core net income attributable to Kindred, core EBITDAR and core
diluted EPS, by excluding charges related to transaction,
integration, severance, retirement, retention, impairments,
business interruption settlements, research and development,
restructuring, debt amendment costs, and litigation. The Company
believes that the presentation of core operating results provides
additional information to investors to facilitate the comparison
between periods by excluding certain charges that are not
representative of its ongoing operations due to the materiality and
nature of the charges. The Company’s management uses core net
income attributable to Kindred, core EBITDAR and core diluted EPS
as meaningful measures of operational performance, and for the
attainment of internal incentive compensation goals, in addition to
other measures. The Company uses these measures to assess the
relative performance and attainment of internal incentive
compensation goals of its operating divisions, as well as the
employees that operate these businesses. In addition, the Company
believes these measures are important, because securities analysts
and investors use these measures to compare the Company’s
performance to other companies in the healthcare industry.
Non-GAAP Measurements (Continued) Same-Hospital
Revenues: The same-hospital revenues are calculated by excluding
from the Company's Hospital Division revenues the results from five
hospitals acquired in 2016, three hospitals sold in 2016, three
hospitals that closed during 2016, and two hospitals that closed
during 2015. The Company believes the presentation of same-hospital
revenues provides investors, equity analysts and others with useful
information regarding the performance of the Company's hospital
operations that are comparable for the periods presented.
For EBITDAR, core net income attributable to Kindred, and core
EBITDAR, the Company believes that income (loss) from continuing
operations is the most comparable GAAP measure. For core diluted
EPS, the Company believes that GAAP diluted earnings (loss) per
share from continuing operations is the most comparable GAAP
measure. Readers of the Company’s financial information should
consider income (loss) from continuing operations and diluted
earnings (loss) per share from continuing operations as important
measures of the Company’s financial performance, because they
provide the most complete measures of its performance. For
same-hospital revenues, the Company believes that reported hospital
segment revenues is the most comparable GAAP measure. Readers of
the Company’s financial information should consider reported
hospital segment revenues as an important measure of the Company’s
Hospital Division financial performance because it provides the
most complete measure of its performance. Operating results
presented on a core basis, as well as a same-hospital basis, should
be considered in addition to, not as a substitute for, or superior
to, financial measures based upon GAAP as an indicator of operating
performance. Also in this earnings release, the Company
provides the financial measures of operating cash flows and free
cash flows excluding certain items, which the Company refers to as
core operating cash flows and core free cash flows, respectively.
Core Operating Cash Flows: The Company defines core
operating cash flows as operating cash flows excluding payments
related to transaction, severance, retirement, retention, business
interruption settlements, research and development, restructuring
charges, debt amendment costs, and litigation, net of income tax
benefits. The Company believes that core operating cash flows
provide important information to investors for comparability to
other companies that use similar measures. Management uses core
operating cash flows to evaluate consolidated operating performance
and in making decisions related to acquisitions, development
capital expenditures, dividends, long-term debt repayments and
other uses. Core Free Cash Flows: The Company defines core
free cash flows as operating cash flows excluding payments related
to transaction, severance, retirement, retention, business
interruption settlements, research and development, restructuring
charges, debt amendment costs, and litigation, net of income tax
benefits but including routine capital expenditures and
distributions to noncontrolling interests. The Company believes
that core free cash flows provide important information to
investors for comparability to other companies that use similar
measures. Management uses core free cash flows in making decisions
related to acquisitions, development capital expenditures,
dividends, long-term debt repayments and other uses. The
Company recognizes that core operating cash flows and core free
cash flows are non-GAAP measures and are not intended to replace
the presentation of the Company’s cash flows in accordance with
GAAP. For core operating cash flows and core free cash flows, the
Company believes net cash flows provided by operating activities is
the most comparable GAAP measure. Readers of the Company’s
financial information should consider net cash flows provided by
operating activities as an important measure because it provides
the most complete measure of cash provided by operating activities.
Core operating cash flows and core free cash flows should be
considered in addition to, not as a substitute for, or superior to,
financial measures based upon GAAP as an indicator of the Company’s
cash flows provided by operating activities.
KINDRED HEALTHCARE, INC. Reconciliation of GAAP Results
to Non-GAAP Measurements (Unaudited) (In thousands,
except per share amounts and statistics)
In addition to the results
provided in accordance with GAAP, the Company has provided
information in this earnings release to compute certain non-GAAP
measurements for the three months and nine months ended September
30, 2016 and 2015 before certain charges or on a core basis. The
charges that were excluded from core operating results are denoted
in the tables below. The income tax benefit associated with
the excluded charges was calculated using an effective income tax
rate of 67.1% and 6.9% for the three months ended September 30,
2016 and 2015, respectively, and 60.5% and 19.7% for the nine
months ended September 30, 2016 and 2015, respectively. The
difference in the effective income tax rate for both periods
compared to the same prior year periods is attributable to the
deferred tax valuation allowance and the composition of charges
that are non-deductible for income tax purposes, including the
impairment charges and litigation contingency expense.
Three months ended Nine months ended September
30, September 30, 2016 2015 2016
2015 Reconciliation of income from continuing operations
before charges: As reported: Loss from continuing operations
attributable to Kindred ($685,600 ) ($16,869 ) ($651,418 )
($138,329 ) Diluted loss per common share from continuing
operations ($7.89 ) ($0.20 ) ($7.51 ) ($1.65 ) Weighted average
diluted shares outstanding 86,869 86,184 86,766 83,960
Detail of charges: Restructuring charges: Facility/branch
divestitures and closings ($20,212 ) ($2,416 ) ($22,234 ) ($6,439 )
Severance costs (2,109 ) (125 ) (5,049 ) (523 ) Transaction costs
(492 ) - (1,577 ) -
(22,813 ) (2,541 ) (28,860 ) (6,962 ) Lease termination costs
(charged to rent expense) (58,650 ) (808 ) (59,363 ) (1,831 )
Impairment charges (324,289 ) - (338,208 ) - Research and
development (3,288 ) - (7,227 ) - Litigation contingency expense -
(31,462 ) (2,840 ) (130,387 ) Other retirement and severance costs
- (666 ) (658 ) (5,627 ) Other facility/branch
sales/closings/consolidations (821 ) (827 ) (821 ) (2,086 )
Business interruption settlements - - 1,309 - Debt amendment fees
not capitalized - - (1,103 ) - Gentiva transaction costs:
Professional and consulting fees (1,464 ) (1,113 ) (3,831 ) (35,178
) Severance and retention 214 (1,956 ) (696 ) (58,831 ) Lease
termination (charged to rent expense) (272 ) - (272 ) (792 )
Pre-closing financing charges (charged to general and
administrative expenses) - - - (6,005 ) Pre-closing financing
charges (charged to interest expense) - - - (17,431 ) Trade name
impairment charges - - - (6,726 ) Other transaction costs
(1,732 ) (777 ) (1,986 ) (3,750 ) (413,115 )
(40,150 ) (444,556 ) (275,606 ) Income tax benefit (277,113
) 2,775 (268,868 ) 54,302
Charges net of income taxes (690,228 ) (37,375 ) (713,424 )
(221,304 ) Noncontrolling interest adjustment related to impairment
charges 288 - 1,304
- (689,940 ) (37,375 ) (712,120 ) (221,304 )
Allocation to participating unvested restricted stockholders
- - - - Available
to common stockholders ($689,940 ) ($37,375 )
($712,120 ) ($221,304 ) Diluted loss per common share
related to charges ($7.94 ) ($0.43 ) ($8.21 ) ($2.64 )
Weighted average diluted shares outstanding 86,869 86,184 86,766
83,960 Core: Income from continuing operations before
charges $ 4,340 $ 20,506 $ 60,702 $ 82,975 Diluted earnings per
common share from continuing operations before charges (a) $ 0.05 $
0.23 $ 0.68 $ 0.95
Weighted average diluted shares
outstanding used to compute earnings per common share from
continuing operations before charges
87,529 86,892 87,426 85,691 Reconciliation of effective
income tax rate before charges: Effective income tax rate before
charges 19.7 % 33.5 % 29.4 % 35.9 % Impact of charges on effective
income tax rate 52.6 % 192.0 % 74.6 %
-26.6 % Reported effective income tax rate 72.3 %
225.5 % 104.0 % 9.3 %
__________
(a) For purposes of computing diluted
earnings per common share before charges, income from continuing
operations before charges was reduced by $0.1 million and $0.3
million for the three months ended September 30, 2016 and 2015,
respectively, and by $1.3 million and $1.5 million for the nine
months ended September 30, 2016 and 2015, respectively, for the
allocation of income to participating unvested restricted
stockholders.
KINDRED HEALTHCARE, INC. Reconciliation of
GAAP Results to Non-GAAP Measurements (Continued)
(Unaudited) (In thousands)
A reconciliation of combined Kindred and
Gentiva home health revenues (excluding community care) for each
historical period follows:
Third quarter 2015
Quarters 2016 Quarters % change v. First
Second Third Fourth First Second
Third prior year Kindred $ 254,965 $ 360,173 $
356,716 $ 358,075 $ 363,730 $ 370,327 $ 373,980 Gentiva
87,520 - - -
- - - $ 342,485 $ 360,173
$ 356,716 $ 358,075 $ 363,730 $ 370,327
$ 373,980 4.8 A reconciliation of
reported revenues to same-hospital revenues for the Hospital
Division for each historical period follows:
Third
quarter 2015 Quarters 2016 Quarters % change
v. First Second Third Fourth
First Second Third prior year Reported
revenues $ 640,483 $ 627,206 $ 579,497 $ 593,593 $ 643,299 $
633,695 $ 575,323 (0.7 ) Hospitals acquired and sold during 2016
(a) - (16,608 ) (14,679 ) (14,695 ) - (14,346 ) (13,731 ) Hospitals
closed during 2016 (b) - - (7,376 ) (7,471 ) - - (5,447 ) Hospitals
closed during 2015 (c) (5,508 ) (5,188 )
(2,160 ) 498 114 78 (54 )
Same-hospital revenues $ 634,975 $ 605,410 $ 555,282
$ 571,925 $ 643,413 $ 619,427 $ 556,091
0.1
__________
(a) Five hospitals acquired and three
hospitals sold during the second quarter of 2016.
(b) Three hospitals closed during the
third quarter of 2016.
(c) One hospital closed during the second
quarter of 2015 and one hospital closed during the third quarter of
2015.
KINDRED HEALTHCARE, INC. Reconciliation of
GAAP Results to Non-GAAP Measurements (Continued)
(Unaudited) (In thousands, except per share amounts)
Three months ended September 30, 2016 Charges
Gentiva Deferred Facility/ transaction
tax Before As branch Impairment
Research and Restructuring and Other
valuation charges reported closings
charges development charges integration
transaction allowance Total ("core")
Income (loss) from continuing operations: Segment EBITDAR:
Hospital division $ 82,752 $ - $ - $ - $ - $ - $ - $ - $ - $ 82,752
Kindred at Home: Home health 75,073 - - - - - - - - 75,073
Hospice 31,326 - - -
- - - - -
31,326 106,399 - -
- - - - - -
106,399 Kindred Rehabilitation Services: Kindred
Hospital Rehabilitation Services 49,470 747 - - - - - - 747 50,217
RehabCare 9,248 - - -
- - - - -
9,248 58,718 747 -
- - - - - 747
59,465 Nursing center division 29,922 - - - -
- - - - 29,922 Support center (61,751 ) - - 3,288 - - - -
3,288 (58,463 ) Impairment charges (324,289 ) - 324,289 - - - - -
324,289 - Restructuring charges (22,813 ) - - - 22,813 - - - 22,813
- Transaction costs (2,982 ) - -
- - 1,250 1,732 - 2,982
- EBITDAR (134,044 ) 747 324,289 3,288 22,813
1,250 1,732 - 354,119 220,075 Rent (98,415 ) 74 - - - 272 - - 346
(98,069 ) Restructuring charges - rent (58,650 ) - - - 58,650 - - -
58,650 - Depreciation and amortization (40,382 ) - - - - - - - -
(40,382 ) Interest, net (58,052 ) - -
- - - - - -
(58,052 )
Income (loss) from continuing operations
before income taxes
(389,543 ) 821 324,289 3,288 81,463 1,522 1,732 - 413,115 23,572
Provision (benefit) for income taxes 281,752
288 58,173 1,154 28,599 535
608 (366,470 ) (277,113 ) 4,639
(671,295 ) 533 266,116 2,134 52,864 987 1,124 366,470 690,228
18,933 Noncontrolling interests (14,305 ) -
(288 ) - - - - -
(288 ) (14,593 ) Income (loss) attributable to Kindred $
(685,600 ) $ 533 $ 265,828 $ 2,134 $ 52,864 $ 987 $ 1,124 $
366,470 $ 689,940 $ 4,340 Diluted
earnings (loss) per common share $ (7.89 ) $ 0.05
Diluted shares used in computing earnings
(loss) per common share
86,869 87,529
Three months ended September
30, 2015 Charges Gentiva Retirement
Facility/ transaction Before As
and branch Litigation Restructuring
and Other charges reported
severance closings contingency charges
integration transaction Total ("core")
Income from continuing operations: Segment EBITDAR: Hospital
division $ 96,108 $ 666 $ 354 $ - $ - $ - $ - $ 1,020 $ 97,128
Kindred at Home: Home health 67,682 - 473 - - - - 473 68,155
Hospice 34,025 - - -
- - - - 34,025
101,707 - 473 - -
- - 473 102,180
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 42,141 - - - - - - - 42,141 RehabCare 14,544
- - - - - -
- 14,544 56,685 -
- - - - - -
56,685 Nursing center division 35,923 - - - - - - -
35,923 Support center (55,439 ) - - - - - - - (55,439 )
Litigation contingency expense (31,462 ) - - 31,462 - - - 31,462 -
Restructuring charges (2,541 ) - - - 2,541 - - 2,541 - Transaction
costs (3,846 ) - - - -
3,069 777 3,846 - EBITDAR
197,135 666 827 31,462 2,541 3,069 777 39,342 236,477 Rent (95,436
) - - - - - - - (95,436 ) Restructuring charges - rent (808 ) - - -
808 - - 808 - Depreciation and amortization (39,329 ) - - - - - - -
(39,329 ) Interest, net (56,008 ) - -
- - - - - (56,008
)
Income from continuing operations before
income taxes
5,554 666 827 31,462 3,349 3,069 777 40,150 45,704 Provision for
income taxes 12,523 196 243
429 982 697 228 2,775
15,298 (6,969 ) $ 470 $ 584 $ 31,033 $ 2,367 $
2,372 $ 549 $ 37,375 30,406 Noncontrolling interests
(9,900 ) (9,900 ) Income (loss) attributable to Kindred $
(16,869 ) $ 20,506 Diluted earnings (loss) per common
share $ (0.20 ) $ 0.23
Diluted shares used in computing earnings
(loss) per common share
86,184 86,892
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Nine months ended September 30, 2016
Charges Gentiva Deferred Retirement
Facility/ Business transaction tax
Before As and branch
interruption Litigation Impairment Research
and Debt Restructuring and Other
valuation charges reported severance
closings settlements contingency
charges development amendment charges
integration transaction allowance Total
("core") Income (loss) from continuing operations:
Segment EBITDAR: Hospital division $ 344,179 $ - $ - $ - $ - $ - $
- $ - $ - $ - $ - $ - $ - $ 344,179 Kindred at Home: Home
health 218,044 - - (1,309 ) - - - - - - - - (1,309 ) 216,735
Hospice 87,521 - - -
- - - - - -
- - - 87,521
305,565 - - (1,309 ) -
- - - - - -
- (1,309 ) 304,256
Kindred Rehabilitation Services: Kindred Hospital Rehabilitation
Services 147,809 - 747 - - - - - - - - - 747 148,556 RehabCare
34,504 - - - -
- - - - - -
- - 34,504 182,313
- 747 - - -
- - - - - -
747 183,060 Nursing center
division 93,684 - - - - - - - - - - - - 93,684 Support
center (199,363 ) 658 - - - - 7,227 1,103 - - - - 8,988 (190,375 )
Litigation contingency expense (2,840 ) - - - 2,840 - - - - - - -
2,840 - Impairment charges (338,208 ) - - - - 338,208 - - - - - -
338,208 - Restructuring charges (28,860 ) - - - - - - - 28,860 - -
- 28,860 - Transaction costs (6,513 ) - -
- - - - - -
4,527 1,986 - 6,513
- EBITDAR 349,957 658 747 (1,309 ) 2,840
338,208 7,227 1,103 28,860 4,527 1,986 - 384,847 734,804 Rent
(296,025 ) - 74 - - - - - - 272 - - 346 (295,679 ) Restructuring
charges - rent (59,363 ) - - - - - - - 59,363 - - - 59,363 -
Depreciation and amortization (121,320 ) - - - - - - - - - - - -
(121,320 ) Interest, net (172,856 ) - -
- - - - - -
- - - - (172,856 )
Income (loss) from continuing operations
before income taxes
(299,607 ) 658 821 (1,309 ) 2,840 338,208 7,227 1,103 88,223 4,799
1,986 - 444,556 144,949 Provision (benefit) for income taxes
311,470 235 293 (468 ) 32
64,179 2,582 394 27,930 1,715
710 (366,470 ) (268,868 ) 42,602
(611,077 ) 423 528 (841 ) 2,808 274,029 4,645 709 60,293
3,084 1,276 366,470 713,424 102,347 Noncontrolling interests
(40,341 ) - - - - (1,304
) - - - - - -
(1,304 ) (41,645 ) Income (loss) attributable
to Kindred $ (651,418 ) $ 423 $ 528 $ (841 ) $ 2,808 $ 272,725
$ 4,645 $ 709 $ 60,293 $ 3,084 $ 1,276 $ 366,470
$ 712,120 $ 60,702 Diluted earnings
(loss) per common share $ (7.51 ) $ 0.68
Diluted shares used in computing earnings
(loss) per common share
86,766 87,426
Nine months ended September
30, 2015 Charges Gentiva Gentiva
Retirement Facility/ pre-closing
transaction Before As and branch
Litigation Impairment Restructuring
financing and Other charges
reported severance closings contingency
charges charges costs integration
transaction Total ("core") Income (loss)
from continuing operations: Segment EBITDAR: Hospital division
$ 361,751 $ 666 $ 1,029 $ - $ - $ - $ - $ - $ - $ 1,695 $ 363,446
Kindred at Home: Home health 187,397 - 473 - - - - - - 473
187,870 Hospice 78,908 - - -
- - - - - -
78,908 266,305 - 473
- - - - - -
473 266,778 Kindred Rehabilitation
Services: Kindred Hospital Rehabilitation Services 131,236 - - - -
- - - - - 131,236 RehabCare 44,933 785
- - - - - -
- 785 45,718 176,169 785
- - - - - -
- 785 176,954 Nursing center
division 112,763 - 584 - - - - - - 584 113,347 Support
center (192,213 ) 4,176 - - - - - - - 4,176 (188,037 ) Litigation
contingency expense (130,387 ) - - 130,387 - - - - - 130,387 -
Impairment charges (6,726 ) - - - 6,726 - - - - 6,726 -
Restructuring charges (6,962 ) - - - - 6,962 - - - 6,962 -
Transaction costs (103,764 ) - - -
- - 6,005 94,009
3,750 103,764 - EBITDAR 476,936 5,627 2,086
130,387 6,726 6,962 6,005 94,009 3,750 255,552 732,488 Rent
(282,955 ) - - - - - - 792 - 792 (282,163 ) Restructuring charges -
rent (1,831 ) - - - - 1,831 - - - 1,831 - Depreciation and
amortization (116,889 ) - - - - - - - - - (116,889 ) Interest, net
(173,925 ) - - - -
- 17,431 - - 17,431
(156,494 )
Income (loss) from continuing operations
before income taxes
(98,664 ) 5,627 2,086 130,387 6,726 8,793 23,436 94,801 3,750
275,606 176,942 Provision (benefit) for income taxes 9,183
2,202 816 2,108 2,633
3,442 9,173 32,460 1,468
54,302 63,485 (107,847 ) $ 3,425 $ 1,270 $ 128,279
$ 4,093 $ 5,351 $ 14,263 $ 62,341 $ 2,282 $ 221,304
113,457 Noncontrolling interests (30,482 ) (30,482 )
Income (loss) attributable to Kindred $ (138,329 ) $ 82,975
Diluted earnings (loss) per common share $ (1.65 ) $ 0.95
Diluted shares used in computing earnings
(loss) per common share
83,960 85,691
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended March 31,
2016 Charges Gentiva Retirement
Business transaction Before As
and interruption Litigation Impairment
Research and Restructuring and Other
charges reported severance settlements
contingency charges development charges
integration transaction Total ("core")
Income from continuing operations: Segment EBITDAR: Hospital
division $ 135,495 $ - $ - $ - $ - $ - $ - $ - $ - $ - $ 135,495
Kindred at Home: Home health 66,941 - (1,138 ) - - - - - -
(1,138 ) 65,803 Hospice 24,866 - -
- - - - - -
- 24,866 91,807 -
(1,138 ) - - - - - -
(1,138 ) 90,669 Kindred Rehabilitation
Services: Kindred Hospital Rehabilitation Services 47,870 - - - - -
- - - - 47,870 RehabCare 11,987 - -
- - - - - -
- 11,987 59,857 -
- - - - - - -
- 59,857 Nursing center division
30,100 - - - - - - - - - 30,100 Support center (70,808 ) 658
- - - 863 - - - 1,521 (69,287 ) Litigation contingency expense
(1,910 ) - - 1,910 - - - - - 1,910 - Impairment charges (7,788 ) -
- - 7,788 - - - - 7,788 - Restructuring charges (1,701 ) - - - - -
1,701 - - 1,701 - Transaction costs (1,685 ) -
- - - - - 1,603 82
1,685 - EBITDAR 233,367 658 (1,138 )
1,910 7,788 863 1,701 1,603 82 13,467 246,834 Rent (97,517 ) - - -
- - - - - - (97,517 ) Restructuring charges - rent (251 ) - - - - -
251 - - 251 - Depreciation and amortization (40,681 ) - - - - - - -
- - (40,681 ) Interest, net (57,245 ) - -
- - - - - -
- (57,245 )
Income from continuing operations before
income taxes
37,673 658 (1,138 ) 1,910 7,788 863 1,952 1,603 82 13,718 51,391
Provision for income taxes 11,836 226
(391 ) 656 2,674 296 670 551
28 4,710 16,546 25,837 $ 432 $
(747 ) $ 1,254 $ 5,114 $ 567 $ 1,282 $ 1,052 $ 54 $ 9,008
34,845 Noncontrolling interests (12,514 ) (12,514 )
Income attributable to Kindred $ 13,323 $ 22,331
Diluted earnings per common share $ 0.15 $ 0.25
Diluted shares used in computing earnings
per common share
87,249 87,249
Three months ended March 31,
2015 Charges Gentiva Gentiva
Retirement Facility/ pre-closing
transaction Before As and branch
Litigation Impairment Restructuring
financing and Other charges
reported severance closings contingency
charges charges costs integration
transaction Total ("core") Income (loss)
from continuing operations: Segment EBITDAR: Hospital division
$ 134,111 $ - $ 675 $ - $ - $ - $ - $ - $ - $ 675 $ 134,786
Kindred at Home: Home health 46,798 - - - - - - - - - 46,798
Hospice 16,996 - - -
- - - - - -
16,996 63,794 - -
- - - - - - -
63,794 Kindred Rehabilitation Services:
Kindred Hospital Rehabilitation Services 44,564 - - - - - - - - -
44,564 RehabCare 15,708 785 -
- - - - - - 785
16,493 60,272 785
- - - - - - -
785 61,057 Nursing center
division 36,963 - - - - - - - - - 36,963 Support center
(66,565 ) 4,176 - - - - - - - 4,176 (62,389 ) Litigation
contingency expense (95,000 ) - - 95,000 - - - - - 95,000 -
Impairment charges (6,726 ) - - - 6,726 - - - - 6,726 -
Restructuring charges (1,619 ) - - - - 1,619 - - - 1,619 -
Transaction costs (94,702 ) - -
- - - 6,005 86,598 2,099
94,702 - EBITDAR 30,528 4,961 675 95,000 6,726
1,619 6,005 86,598 2,099 203,683 234,211 Rent (91,788 ) - - - - - -
589 - 589 (91,199 ) Restructuring charges - rent (352 ) - - - - 352
- - - 352 - Depreciation and amortization (38,935 ) - - - - - - - -
- (38,935 ) Interest, net (61,777 ) - -
- - - 17,431 - -
17,431 (44,346 )
Income (loss) from continuing operations
before income taxes
(162,324 ) 4,961 675 95,000 6,726 1,971 23,436 87,187 2,099 222,055
59,731 Provision (benefit) for income taxes (27,736 )
2,133 290 - 2,891 848
10,075 33,063 902 50,202 22,466
(134,588 ) $ 2,828 $ 385 $ 95,000 $ 3,835 $ 1,123 $
13,361 $ 54,124 $ 1,197 $ 171,853 37,265 Noncontrolling
interests (8,847 ) (8,847 ) Income (loss)
attributable to Kindred $ (143,435 ) $ 28,418 Diluted
earnings (loss) per common share $ (1.80 ) $ 0.34
Diluted shares used in computing earnings
(loss) per common share
79,575 82,422
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended June 30,
2016 Charges Gentiva Business
transaction Before As interruption
Litigation Impairment Research and Debt
Restructuring and Other charges
reported settlements contingency
charges development amendment charges
integration transaction Total ("core")
Income from continuing operations: Segment EBITDAR: Hospital
division $ 125,932 $ - $ - $ - $ - $ - $ - $ - $ - $ - $ 125,932
Kindred at Home: Home health 76,030 (171 ) - - - - - - -
(171 ) 75,859 Hospice 31,329 - -
- - - - -
- - 31,329 107,359
(171 ) - - -
- - - - (171 )
107,188 Kindred Rehabilitation Services:
Kindred Hospital Rehabilitation Services 50,469 - - - - - - - - -
50,469 RehabCare 13,269 - -
- - - - -
- - 13,269 63,738
- - - -
- - - - -
63,738 Nursing center division 33,662 - - - -
- - - - - 33,662 Support center (66,804 ) - - - 3,076 1,103
- - - 4,179 (62,625 ) Litigation contingency expense (930 ) - 930 -
- - - - - 930 - Impairment charges (6,131 ) - - 6,131 - - - - -
6,131 - Restructuring charges (4,346 ) - - - - - 4,346 - - 4,346 -
Transaction costs (1,846 ) - -
- - - - 1,674
172 1,846 - EBITDAR
250,634 (171 ) 930 6,131 3,076 1,103 4,346 1,674 172 17,261 267,895
Rent (100,093 ) - - - - - - - - - (100,093 ) Restructuring charges
- rent (462 ) - - - - - 462 - - 462 - Depreciation and amortization
(40,257 ) - - - - - - - - - (40,257 ) Interest, net (57,559
) - - - - -
- - - -
(57,559 )
Income from continuing operations before
income taxes
52,263 (171 ) 930 6,131 3,076 1,103 4,808 1,674 172 17,723 69,986
Provision for income taxes 17,882 (123 )
(1,307 ) 4,403 2,209 792
(3,765 ) 1,202 124 3,535
21,417 34,381 (48 ) 2,237 1,728 867 311 8,573 472 48 14,188
48,569 Noncontrolling interests (13,522 ) -
- (1,016 ) - - -
- - (1,016 ) (14,538 ) Income
attributable to Kindred $ 20,859 $ (48 ) $ 2,237 $
712 $ 867 $ 311 $ 8,573 $ 472 $ 48 $ 13,172
$ 34,031 Diluted earnings per common share $
0.23 $ 0.38
Diluted shares used in computing earnings
per common share
87,500 87,500
Three months ended June 30,
2015 Charges Gentiva Facility/
transaction Before As branch
Litigation Restructuring and Other
charges reported closings contingency
charges integration transaction Total
("core") Income from continuing operations: Segment
EBITDAR: Hospital division $ 131,532 $ - $ - $ - $ - $ - $ - $
131,532 Kindred at Home: Home health 72,917 - - - - - -
72,917 Hospice 27,887 - -
- - - - 27,887
100,804 - -
- - - - 100,804
Kindred Rehabilitation Services: Kindred Hospital
Rehabilitation Services 44,531 - - - - - - 44,531 RehabCare
14,681 - - -
- - - 14,681
59,212 - - -
- - - 59,212
Nursing center division 39,877 584 - - - - 584 40,461
Support center (70,209 ) - - - - - - (70,209 ) Litigation
contingency expense (3,925 ) - 3,925 - - - 3,925 - Restructuring
charges (2,802 ) - - 2,802 - - 2,802 - Transaction costs
(5,216 ) - - -
4,342 874 5,216 - EBITDAR
249,273 584 3,925 2,802 4,342 874 12,527 261,800 Rent (95,731 ) - -
- 203 - 203 (95,528 ) Restructuring charges - rent (671 ) - - 671 -
- 671 - Depreciation and amortization (38,625 ) - - - - - - (38,625
) Interest, net (56,140 ) - -
- - - - (56,140 )
Income from continuing operations before
income taxes
58,106 584 3,925 3,473 4,545 874 13,401 71,507 Provision for income
taxes 24,396 62 416
368 386 93 1,325
25,721 33,710 $ 522 $ 3,509 $ 3,105 $
4,159 $ 781 $ 12,076 45,786 Noncontrolling interests
(11,735 ) (11,735 ) Income attributable to Kindred $ 21,975
$ 34,051 Diluted earnings per common share $
0.25 $ 0.39
Diluted shares used in computing earnings
per common share
86,402 86,402
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands, except per share
amounts)
Three months ended December
31, 2015 Charges RehabCare Gentiva
Retirement Facility/ customer
transaction Before As and branch
contract Litigation Impairment
Restructuring and Other charges
reported severance closings litigation
contingency charges charges integration
transaction Total ("core") Income from
continuing operations: Segment EBITDAR: Hospital division $
116,454 $ 1,221 $ - $ - $ - $ - $ - $ - $ - $ 1,221 $ 117,675
Kindred at Home: Home health 68,776 - 50 - - - - - - 50
68,826 Hospice 30,212 - - -
- - - - - -
30,212 98,988 - 50
- - - - - - 50
99,038 Kindred Rehabilitation Services:
Kindred Hospital Rehabilitation Services 44,891 207 - - - - - - -
207 45,098 RehabCare (1,118 ) 112 -
12,864 - - - - -
12,976 11,858 43,773 319
- 12,864 - - - -
- 13,183 56,956 Nursing
center division 36,601 - - - - - - - - - 36,601 Support
center (63,016 ) 585 - - - - - - - 585 (62,431 ) Litigation
contingency expense (8,261 ) - - - 8,261 - - 8,261 - Impairment
charges (18,031 ) - - - - 18,031 - - - 18,031 - Restructuring
charges (3,288 ) - - - - - 3,288 - - 3,288 - Transaction costs
(5,367 ) - - - - -
- 4,189 1,178 5,367 -
EBITDAR 197,853 2,125 50 12,864 8,261 18,031 3,288 4,189
1,178 49,986 247,839 Rent (96,934 ) - - - - - - - - - (96,934 )
Restructuring charges - rent (889 ) - - - - - 889 - - 889 -
Depreciation and amortization (40,362 ) - - - - - - - - - (40,362 )
Interest, net (55,664 ) - - - -
- - - - -
(55,664 )
Income from continuing operations before
income taxes
4,004 2,125 50 12,864 8,261 18,031 4,177 4,189 1,178 50,875 54,879
Provision (benefit) for income taxes (51,980 ) 836
20 5,062 50,329 6,205
1,643 1,487 156 65,738 13,758
55,984 $ 1,289 $ 30 $ 7,802 $ (42,068 ) $ 11,826 $ 2,534 $
2,702 $ 1,022 $ (14,863 ) 41,121 Noncontrolling interests
(12,082 ) (12,082 ) Income attributable to Kindred $ 43,902
$ 29,039 Diluted earnings per common share $
0.50 $ 0.33
Diluted shares used in computing earnings
per common share
87,232 87,232
KINDRED HEALTHCARE, INC.
Reconciliation of GAAP Results to Non-GAAP Measurements
(Continued) (Unaudited) (In thousands)
Three months ended
Nine months ended September 30, September 30,
2016 2015 2016 2015
Reconciliation of net cash flows provided by operating activities
to free cash flows: Net cash flows provided by operating activities
$ 36,082 $ 132,290
$ 38,048 $ 93,067
Adjustments to remove certain payments
(including payments made for discontinued operations) included in
net cash flows provided by operating activities:
Transaction, severance, retirement and retention
8,898 5,251
20,989 102,100 Business interruption settlements
- -
(1,309 ) - Ventas, Inc. lease termination fee
- -
3,500 40,000 Capitalized lender fees related to
debt refinancing
42 -
7,375 28,012 Other debt
refinancing costs (expensed)
291 13,438
917 40,439
Other lease termination fees
- -
- 353 Litigation
3,074 -
133,523
16,575
12,305
18,689
164,995 227,479
Net cash flows provided by operating
activities excluding certain items before income tax benefit of
certain payments
48,387 150,979
203,043 320,546 Benefit of reduced
income tax payments resulting from certain payments
(18,048 ) (22,541 )
(46,674
) (56,295 )
Net cash flows provided by operating
activities excluding certain items (core operating cash flows)
30,339 128,438
156,369 264,251 Less routine
capital expenditures
(21,873 ) (35,422 )
(68,703 ) (80,691 ) Less distributions to
noncontrolling interests
(4,694 )
(10,685 )
(35,240 ) (31,823 ) Free cash
flows excluding certain items (core free cash flows)
$
3,772 $ 82,331
$ 52,426 $
151,737
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161107006523/en/
Kindred Healthcare, Inc.Todd Flowers, 502-596-6569Investor
Relations
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024